Articles tagged with Squamous Cell Carcinoma
A recent study by NTU Singapore has found a strong link between increasing air pollution and the rise of lung adenocarcinoma, a type of cancer. The study also discovered that declining smoking rates are associated with lower incidence of lung squamous cell carcinoma.
Non-melanoma basal and squamous cell skin cancers saw a 30% rise in Ontario over 15 years, mostly among people under age 35. The annual mortality rates increased by almost 5-fold, with males experiencing higher rates than females.
A comprehensive molecular map of lung squamous cell carcinoma has identified potential new drug targets, including the gene NSD3, and highlighted immune regulation pathways that could help cancer evade immunotherapies. The study's findings have also revealed metabolic dysregulation and crosstalk between different cellular processes.
Researchers analyzed 430 lung squamous tumors and identified mutations in genes such as TP53, CDKN2A, and FGFR1. The study found that 13.5% of patients with druggable mutations had lower median overall survival.
Research identifies novel E6 inhibitors with potential for targeted therapy in HPV-positive head and neck squamous cell carcinomas. The study reveals the key role of E6 in tumor formation and growth, highlighting its importance as a strategic approach for HPV-positive HNSCC treatment.
A study characterized genomic and neoantigen evolution between primary and first recurrence tumors in 23 HNSCC patients, identifying shared genes with predicted neoantigens. Patients with these shared neoantigens tend to have increased duration of survival with disease.
Researchers are using AI to improve treatment outcomes for patients with oral squamous cell carcinomas by predicting which patients need chemotherapy, radiation, or surgery. The project aims to develop a more precise and personalized approach to cancer care.
A new method uses conductive polymer spray ionization mass spectrometry and machine learning to detect changes in metabolites in saliva samples from 373 volunteers. The diagnostic accuracy of the method is reported at 86.7%, suggesting a potential point-of-care test for oral squamous cell carcinoma.
Researchers characterized bacteriome, mycobiome, and mycobiome-bacteriome interactions of oral wash in Head and neck squamous cell carcinoma patients, finding distinct differences compared to healthy controls. Unique interactions between fungal and bacterial communities may serve as potential screening tool for HNSCC.
A research team led by University of Würzburg scientists has found a way to inactivate the cancer protein NP63, which is crucial for squamous cell carcinoma growth. By using a preclinical inhibitor, they were able to switch off NP63's parking ticket remover and stop tumor cells from growing.
Researchers found that Clostridium perfringens enterotoxin induces CLDN4 nuclear translocation, enhancing epithelial-mesenchymal transition, stemness, and invasive ability in oral squamous cell carcinoma cells. The complex of YAP1, CLDN4, and zona occludens-2 was formed by CPE treatment, suppressing YAP1 phosphorylation and activating it.
Researchers found a new long non-coding RNA, PRECSIT, that regulates the growth and invasion of squamous cell carcinoma in skin. PRECSIT's expression is linked to the tumor suppressor gene p53, promoting cancer progression via STAT3 signaling.
Researchers analyzed the virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis, finding correlations between specific viruses and clinical outcomes. The study suggests that certain viral signatures may impact tumor biology and behavior, offering potential avenues for future research and treatment.
The GW Cancer Center is conducting a phase II clinical trial examining the safety and effectiveness of Libtayo in reducing tumor size and preventing recurrence in high-risk cutaneous squamous cell carcinoma. The study aims to enroll over 75 participants and build on preliminary results from similar trials.
A large Norwegian study of nearly 160,000 women found a significant association between cumulative exposure to indoor tanning and the development of squamous cell carcinoma. The findings suggest that even short-term indoor tanning can increase cancer risk, emphasizing the importance of sun protection measures.
The GW Cancer Center is conducting a randomized, placebo-controlled phase III trial to investigate cemiplimab's safety and effectiveness in preventing recurrence and metastasis in high-risk cutaneous squamous cell carcinoma. The study aims to enroll over 400 participants worldwide.
A new study reports that cervical adenocarcinoma incidence rates are increasing in non-Hispanic whites, particularly among women aged 40-49 and 50-59. This trend underscores the need for intensified efforts to improve screening utilization and HPV vaccination.
A combination of topical creams reduces precancerous skin lesions and lowers the risk of developing squamous cell carcinoma. The therapy combines 5-fluorouracil with calcipotriol, activating the immune system's T cells to attack tumor cells.
American University researchers identify Tpl2 gene's role in squamous cell carcinoma, revealing potential therapeutic target for advanced cancers. The study shows that blocking the MET receptor reduces tumors by 60%, offering new hope for treatments.
Patients with metastatic non-small cell lung cancer (NSCLC) treated at academic centers had higher 2-year survival rates than those treated at community-based centers. The study found significant differences in survival outcomes based on facility type, histology, and molecular profile.
A study published in Cell Reports has identified Np63a as a driver of squamous cell carcinoma growth and found that activating tumor suppressor genes TGFB2 and RHOA can halt this process. This discovery provides a promising pathway for developing new cancer treatments.
Researchers identified APOBEC enzymes as major contributors to the development of aggressive skin cancer in patients with Butterfly Syndrome. The discovery reveals a mechanism that instigates tissue damage-driven cancers and provides new therapeutic strategies.
Two targeted therapies, MLN128 and CB-839, individually target the metabolism of key nutrients glucose and glutamine, respectively, to treat squamous cell carcinomas of the lung. Researchers found that when used in combination, these drugs could reduce tumor growth in aggressive lung cancer.
Researchers investigated molecular mechanisms behind squamous cell carcinoma, revealing NUP62's role in regulating ΔNp63α nuclear transport. This mechanism is crucial for maintaining SCC cells' undifferentiated status and proliferation.
A recent analysis of published studies found that higher alcohol intake increases the risk of basal cell carcinoma by 7% and cutaneous squamous cell carcinoma by 11% for every 10 gram increase per day. The study suggests that limiting alcohol consumption may help reduce skin cancer risk.
Researchers found that squamous cell carcinoma diagnoses increased by 263% and basal cell carcinomas by 145% between 2000-2010. Women in specific age groups experienced the greatest increase in basal cell carcinoma diagnoses, while men's diagnosis trends varied across time periods.
Researchers at UCLA have discovered that targeting cancer stem cells and killing tumor mass with chemotherapy drugs results in better outcomes for patients with head and neck squamous cell carcinoma. The study also found that cancer stem cells cause cervical lymph node metastasis.
A new study reveals a strong association between human papillomavirus (HPV) types and the risk of head and neck squamous cell carcinoma (HNSCC). Detection of HPV-16 in the oral cavity significantly increases the risk of oropharyngeal squamous cell carcinoma, highlighting the role of HPV in HNSCC.
Research from University of Eastern Finland finds SIP1 protein expression indicates advanced tumour stage, high recurrence risk, and poor prognosis. The study identifies SIP1 as a potential new prognostic factor for clinical use.
Low preoperative serum squamous cell carcinoma antigen levels and absence of tumor invasion into the pleura or blood vessels are independent prognostic factors for patients with peripheral squamous cell carcinomas of the lung. These factors are associated with longer overall survival and reduced disease recurrence.
A phase III trial demonstrated that afatinib significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The study showed a 20% reduction in risk of progression or death, with patients experiencing less pain over time.
A genetic mutation caused by ultraviolet light is linked to millions of human skin cancers, according to Stanford researchers. The mutation occurs in the KNSTRN gene and can cause genomic catastrophe, leading to cutaneous squamous cell carcinomas.
Researchers have identified a link between HPV detection and improved survival rates in patients with oropharyngeal squamous cell carcinoma (OPSCC). A specific pattern of DNA modifications associated with HPV was found to be correlated with better outcomes in OPSCC patients.
A Kaiser Permanente study found basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative. The risk for these cancers is consistent with the growing evidence about this population's increased risk for a broad range of cancers.
A new study confirms a link between indoor tanning and non-melanoma skin cancer, particularly among those exposed before age 25. The research estimates that indoor tanning accounts for hundreds of thousands of new cases each year in the US alone.
A meta-analysis and review of medical literature found a clear association between smoking and an increased risk of cutaneous squamous cell carcinoma. The study, which included data from 11 countries, showed a 52% significant increase in odds for current or ever smokers.
Researchers at Fred Hutchinson Cancer Center have discovered a new drug target for squamous cell carcinoma, the second most common form of skin cancer. The protein alpha-catenin acts as a tumor suppressor and regulates cell proliferation by controlling Yap1 activity in cancer cells.
Sharing educational materials with kidney transplant recipients increased their likelihood of performing self-examinations and detecting skin cancers, according to a randomized controlled trial. The intervention also improved knowledge and attitudes towards skin cancer risk, leading to more follow-up appointments with dermatologists.
A new international multidisciplinary classification of lung adenocarcinoma has been published by three top lung associations. The classification takes a comprehensive approach, incorporating advances in genetics, clinical information, and molecular studies to improve diagnosis and treatment.
A study published in the Journal of the National Cancer Institute found that celecoxib, a widely used arthritis drug, significantly reduces non-melanoma skin cancers. The medication achieved a 68% reduction in basal cell carcinomas and a 58% reduction in squamous cell carcinomas among high-risk patients.
A study has identified the BRF2 oncogene as specifically associated with lung squamous cell carcinoma, potentially serving as an identification marker and novel therapeutic target. Genetic analysis found frequent activation of BRF2 in pre-invasive stages of the disease, suggesting its role in tumorigenesis.
A study comparing preoperative and postoperative chemoradiotherapy to surgery alone in patients with resectable esophageal squamous cell carcinoma found significant differences in overall survival and progression-free survival. Perioperative chemoradiotherapy maximizes long-term survival, but increases toxicity.
According to a study published in Archives of Dermatology, regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is not associated with an increased risk of squamous cell skin cancer. The study found that NSAID users were not at a higher risk for squamous cell carcinoma regardless of duration or dose.
A study of 312 heart transplant patients found that nearly half developed skin cancer during a 19-year follow-up period. The majority of these cancers were squamous cell carcinomas, with risk factors including age, other types of cancer, and immunosuppressive medication use.
Researchers found that E-cadherin and N-cadherin expression is correlated with invasion and aggravation of esophageal squamous cell carcinoma. The down-regulation of N-cadherin decreases invasiveness of esophageal squamous cell carcinoma cells in vitro.
A study found an association between HPV antibodies and squamous cell carcinoma risk, with patients diagnosed with squamous cell carcinoma more frequently testing positive for beta type HPVs. Lifestyle habits, such as sun exposure and smoking, were not significantly linked to skin cancer development.
The study found a significant increase in nonmelanoma skin cancer incidence among young adults, with rates rising by 13.4% for women and 22.9% for men between 1976-1979. Squamous cell carcinoma incidence also increased significantly over the study period, emphasizing the need to focus on prevention.
Combination therapy of radiotherapy and cetuximab significantly improves loco-regional control, median survival, and overall survival rates in patients with loco-regionally advanced squamous cell carcinoma of the oropharynx, hypopharynx, or larynx. The treatment also showed minimal enhancement of toxicity compared to radiotherapy alone.
Patients with massive skin cancers can now experience significant improvement in function, appearance, and quality of life after undergoing free tissue transfer surgery. This innovative technique, pioneered by OHSU researchers, has revolutionized the care of patients with this condition.
A statewide study found that people who used tanning lamps were 2.5 times more likely to develop squamous cell carcinoma and 1.5 times more likely to develop basal cell carcinoma than non-users. The risk of these skin cancers increased with younger age at use.
A new study found that individuals who used tanning devices were 2.5 times more likely to develop squamous cell carcinoma and 1.5 times more likely to develop basal cell carcinoma compared to those who did not use them. The risk of these cancers increased with the age at which participants started using tanning devices.